Cargando…
Death and invasive mechanical ventilation risk in hospitalized COVID-19 patients treated with anti-SARS-CoV-2 monoclonal antibodies and/or antiviral agents: A systematic review and network meta-analysis protocol
BACKGROUND: The ongoing COVID-19 pandemic has claimed >4 million lives globally, and these deaths often occurred in hospitalized patients with comorbidities. Therefore, the proposed review aims to distinguish the inpatient mortality and invasive mechanical ventilation risk in COVID-19 patients tr...
Autor principal: | Saha, Sumanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205473/ https://www.ncbi.nlm.nih.gov/pubmed/35714102 http://dx.doi.org/10.1371/journal.pone.0270196 |
Ejemplares similares
-
Protocol for production and expression of chimeric bovine-human monoclonal antibodies
por: Heydarchi, Behnaz, et al.
Publicado: (2022) -
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
por: Fiaschi, Lia, et al.
Publicado: (2022) -
Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study
por: Ramirez, Giuseppe A., et al.
Publicado: (2023) -
Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
por: Howell, Imran, et al.
Publicado: (2023) -
Antiviral Monoclonal Antibodies: Can They Be More Than Simple Neutralizing Agents?
por: Pelegrin, Mireia, et al.
Publicado: (2015)